Date |
Time |
Source |
Heading |
4/25/2024 | 8:52 | IHNW | FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA |
4/26/2024 | 08:00 | PRNUS | Citius Pharmaceuticals Announces $15 Million Registered.. |
4/11/2024 | 08:30 | PRNUS | Citius Pharmaceuticals Announces Addition of City of Hope to.. |
4/04/2024 | 08:30 | PRNUS | Citius Pharmaceuticals to Present at the LD Micro.. |
3/18/2024 | 08:30 | PRNUS | Citius Pharmaceuticals Announces FDA Acceptance of the BLA.. |
3/07/2024 | 08:30 | PRNUS | Citius Pharmaceuticals, Inc. Secures $2.4 million through.. |
3/04/2024 | 00:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
2/26/2024 | 07:30 | PRNUS | Citius Pharmaceuticals Announces Filing of Form S-3 Shelf.. |
2/23/2024 | 16:23 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
2/23/2024 | 16:18 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
2/23/2024 | 08:30 | PRNUS | Citius Pharmaceuticals to Participate in Upcoming BIO CEO.. |
2/15/2024 | 08:45 | EDGAR2 | Form 8-K - Current report |
2/14/2024 | 16:40 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2/14/2024 | 16:30 | PRNUS | Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter.. |
2/14/2024 | 09:18 | EDGAR2 | Form 8-K - Current report |
2/14/2024 | 08:01 | PRNUS | Citius Pharmaceuticals Resubmits the Biologics License.. |
1/26/2024 | 16:08 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
1/26/2024 | 16:05 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
1/23/2024 | 16:05 | EDGAR2 | Form 8-K - Current report |
1/23/2024 | 08:30 | PRNUS | Citius Pharmaceuticals Announces Nomination of.. |
1/05/2024 | 16:05 | EDGAR2 | Form 8-K - Current report |
1/02/2024 | 16:04 | EDGAR2 | Form 8-K - Current report |
1/02/2024 | 08:31 | PRNUS | Citius Pharmaceuticals Completes Enrollment in Pivotal Phase.. |
1/02/2024 | 08:30 | PRNUS | Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023.. |
12/29/2023 | 16:05 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
11/09/2023 | 08:30 | PRNUS | Citius Pharmaceuticals to Participate in the Sidoti.. |
10/31/2023 | 08:45 | PRNUS | Citius Pharmaceuticals Announces Publication in Frontiers of.. |
10/24/2023 | 07:58 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
10/24/2023 | 07:53 | EDGAR2 | Form 8-K - Current report |
10/24/2023 | 07:30 | GLOBE | Citius Pharmaceuticals Executes Definitive Agreement to.. |
10/12/2023 | 16:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10/12/2023 | 16:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10/12/2023 | 16:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
10/12/2023 | 16:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
9/25/2023 | 16:30 | EDGAR2 | Form 8-K - Current report |
9/21/2023 | 09:35 | GLOBE | Dawson James Securities Announces October Date for 8th.. |
9/18/2023 | 16:30 | PRNUS | Citius Pharmaceuticals Reschedules Participation in Sidoti.. |
9/15/2023 | 16:30 | EDGAR2 | Form 8-K - Current report |
9/13/2023 | 16:30 | PRNUS | Citius Pharmaceuticals Mourns the Loss of Board Member,.. |
9/11/2023 | 09:53 | EDGAR2 | Form 8-K - Current report |
9/08/2023 | 08:40 | EDGAR2 | Form 8-K - Current report |
9/08/2023 | 08:00 | PRNUS | Citius Pharmaceuticals, Inc. Receives Regulatory Guidance.. |
9/06/2023 | 16:30 | PRNUS | Citius Pharmaceuticals to Participate in H.C. Wainwright and.. |
8/15/2023 | 09:25 | EDGAR2 | Form 8-K - Current report |
8/14/2023 | 16:15 | PRNUS | Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter.. |
8/14/2023 | 16:06 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
8/10/2023 | 16:15 | EDGAR2 | Form 8-K - Current report |
8/10/2023 | 08:37 | PRNUS | Citius Pharmaceuticals Reaches 92 Event Milestone in.. |
7/31/2023 | 16:15 | EDGAR2 | Form 8-K - Current report |
7/29/2023 | 16:16 | PRNUS | Citius Pharmaceuticals, Inc. Receives a Complete Response.. |
6/29/2023 | 16:15 | EDGAR2 | Form 8-K - Current report |